Manchester Capital Management’s Surmodics SRDX Stock Holding History

Manchester Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-775	Closed	-$23.7K	–	1231
2025 Q1	$23.7K	Hold	775	–	–	﹤0.01%	684
2024 Q4	$30.7K	Hold	775	–	–	﹤0.01%	643
2024 Q3	$30.1K	Hold	775	–	–	﹤0.01%	636
2024 Q2	$32.6K	Hold	775	–	–	﹤0.01%	582
2024 Q1	$22.7K	Hold	775	–	–	﹤0.01%	546
2023 Q4	$28.2K	Hold	775	–	–	﹤0.01%	489
2023 Q3	$24.9K	Hold	775	–	–	﹤0.01%	501
2023 Q2	$24.3K	Hold	775	–	–	﹤0.01%	483
2023 Q1	$17.7K	Hold	775	–	–	﹤0.01%	504
2022 Q4	$26.4K	Hold	775	–	–	﹤0.01%	401
2022 Q3	$24K	Hold	775	–	–	﹤0.01%	398
2022 Q2	$29K	Hold	775	–	–	0.01%	391
2022 Q1	$35K	Hold	775	–	–	0.01%	422
2021 Q4	$37K	Hold	775	–	–	﹤0.01%	419
2021 Q3	$43K	Hold	775	–	–	0.01%	438
2021 Q2	$42K	Sell	775 -225	-23%	-$12.3K	0.01%	397
2021 Q1	$56K	Hold	1,000	–	–	0.01%	375
2020 Q4	$44K	Buy	+1,000	New	+$39.4K	0.01%	377
2017 Q2	–	Sell	-2,100	Closed	-$51K	–	492
2017 Q1	$51K	Buy	+2,100	New	+$51.5K	0.01%	354
2013 Q3	–	Sell	-1,300	Closed	-$26K	–	986
2013 Q2	$26K	Buy	+1,300	New	+$32.5K	﹤0.01%	714

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Manchester Capital Management's SRDX Position: Q2 2025 in Review

Manchester Capital Management sold out of Surmodics (SRDX) in Q2 2025, closing a stake of 775 shares — an estimated $23.7K sold.

Manchester Capital Management first reported a position in SRDX in Q2 2013 and held it in 20 quarters. The position peaked at $56K in Q1 2021. 135 funds tracked by Wall St. Rank hold SRDX as of Q2 2025.

Manchester Capital Management reported no remaining Surmodics position as of Q2 2025 after selling out during the quarter.
Manchester Capital Management sold 775 Surmodics shares in Q2 2025, an estimated $23.7K.
Manchester Capital Management first reported a position in Surmodics in Q2 2013 and held it in 20 quarters.
Manchester Capital Management's Surmodics position peaked at $56K in Q1 2021.
135 funds tracked by Wall St. Rank held Surmodics as of Q2 2025.

Based on Manchester Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.